![>](style_images/Executiv-909/nav_m.gif)
Pfizer Admits Defeat In AstraZeneca Bid
Month-long takeover battle that pitted two of the world's biggest drugmakers against each other ends as Pfizer abandons its £69.4bn offer
Source
Pfizer To Help 23andMe Unravel Genetic Ties To Bowel Disease
Biotechnology News
Home genetics company 23andMe on Tuesday said it hopes to uncover gene mutations linked to inflammatory bowel disease (IBD) by enrolling 10,000 people with the hard-to-treat malady and examining DNA from their donated saliva samples. The privately held company, founded in 2006 by Anne Wojcicki and backed by Google Inc, said U.S. drugmaker Pfizer Inc will support its latest research effort. "We're hoping within a year or two to have some meaningful genetic data and that it might lead to either an improved therapy or a new therapy for IBD," said Catherine Afarian, a spokeswoman for 23andMe, which is based in Mountain View, California.
Source
Pfizer, now saying its candidate COVID-19 vaccine is 95% effective, plans to start FDA approval process 'within days'. Results Pfizer and partner company BioNTech self-reported on Wednesday indicate the vaccine in development by the two companies has an efficacy rate of 95 percent. This comes on the heels of an announcement earlier this month that its shots were more than 90 percent effective. Drug company Moderna also has a candidate vaccine that is showing similar, self-reported results. The next hurdle is taking these potential vaccines to the Federal Drug Administration for further review. Ref. USAToday.
Pfizer’s COVID-19 vaccine has been endorsed by a key committee, paving the way for FDA clearance and US vaccinations to begin. After a daylong meeting, a committee of leading U.S. Vaccine scientists recommended Thursday the Food and Drug Administration authorize the first COVID-19 vaccine for Americans. The endorsement paves the way for a final decision by the FDA, and mass vaccinations to begin within days in thousands of frontline heath care workers and nursing homes residents. Ref. USAToday.